Table 1.
Characteristics of the Study Population
| Characteristics | Group A (N = 34) | Group B (N = 33) | P |
|---|---|---|---|
| Age (years) | 48 ± 6 | 51 ± 6 | 0.07 |
| BMI (kg/m2) | 22.61 ± 2.51 | 23.52 ± 2.81 | 0.16 |
| SBP (mm Hg) | 119.00 ± 11.54 | 120.84 ± 13.38 | 0.55 |
| DBP (mm Hg) | 79.00 ± 7.38 | 81.16 ± 8.30 | 0.26 |
| h (bpm) | 73.65 ± 4.29 | 73.84 ± 7.06 | 0.89 |
| Cardiovascular history*, n (%) | |||
| Hypertension | 9 (26.5%) | 11 (33.3%) | 0.53 |
| Diabetes mellitus | 5 (14.7%) | 6 (18.2%) | 0.70 |
| Medications, n (%) | |||
| Statin | 7 (20.6%) | 4 (12.1%) | 0.51 |
| Beta-blocker | 4 (11.4%) | 6 (16.7%) | 0.76 |
| ACEI or ARB | 5 (14.7%) | 7 (21.2%) | 0.48 |
| Calcium channel blocker | 7 (20.6%) | 8 (24.2%) | 0.72 |
*Pre-existing known cardiovascular diseases other than hypertension and diabetes mellitus have been excluded before patient recruitment
BMI Body mass index, SBP Systolic blood pressure, DBP Diastolic blood pressure, HR Heart rate, ACEI Angiotensin converting enzyme inhibitor, ARB Angiotensin II receptor blocker